SOX9 somatic mutations are found in about 5%–10% of human CRCs, and most mutations are frameshift or nonsense, suggesting a possible tumor suppressor role of SOX9 in CRCs (7–9, 19). This evidence concerns the gene SOX9 and neoplasm.